Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Rush

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Clinical Therapeutics|January 1, 1996
The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the kneeW Makarowski, A Weaver, B Rubin, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Synthesis and SAR of highly selective MMP-13 inhibitorsJianchang Li, Thomas S Rush, Wei Li, et al.
Nature Communications|February 2, 2022
PplD is a de-N-acetylase of the cell wall linkage unit of streptococcal rhamnopolysaccharidesJeffrey S Rush, Prakash Parajuli, Alessandro Ruda, et al.
Bioorganic & Medicinal Chemistry|October 12, 2005
Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisYonghan Hu, Jason S Xiang, Martin J DiGrandi, et al.
Clinical and Experimental Immunology|July 29, 2025
CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cellsFelix Werner, Jens Wittner, Christian H K Lehmann, et al.
Frontiers in Microbiology|May 21, 2016
Genomic and Secondary Metabolite Analyses of Streptomyces sp. 2AW Provide Insight into the Evolution of the Cycloheximide PathwayElizabeth R Stulberg, Gabriel L Lozano, Jesse B Morin, et al.
Oncotarget|October 3, 2015
IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancerXiaowei Chen, Michael J Churchill, Karan K Nagar, et al.
Bioorganic & Medicinal Chemistry|August 22, 2006
Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based designDésirée H H Tsao, Alan G Sutherland, Lee D Jennings, et al.
Nature Reviews. Drug Discovery|December 6, 2019
Rethinking drug design in the artificial intelligence eraPetra Schneider, W Patrick Walters, Alleyn T Plowright, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA-FtsZ interactionLee D Jennings, Ken W Foreman, Thomas S Rush, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Clinical Therapeutics|January 1, 1996
The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the kneeW Makarowski, A Weaver, B Rubin, et al.
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
Synthesis and SAR of highly selective MMP-13 inhibitorsJianchang Li, Thomas S Rush, Wei Li, et al.
Nature Communications|February 2, 2022
PplD is a de-N-acetylase of the cell wall linkage unit of streptococcal rhamnopolysaccharidesJeffrey S Rush, Prakash Parajuli, Alessandro Ruda, et al.
Bioorganic & Medicinal Chemistry|October 12, 2005
Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisYonghan Hu, Jason S Xiang, Martin J DiGrandi, et al.
Clinical and Experimental Immunology|July 29, 2025
CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cellsFelix Werner, Jens Wittner, Christian H K Lehmann, et al.
Frontiers in Microbiology|May 21, 2016
Genomic and Secondary Metabolite Analyses of Streptomyces sp. 2AW Provide Insight into the Evolution of the Cycloheximide PathwayElizabeth R Stulberg, Gabriel L Lozano, Jesse B Morin, et al.
Oncotarget|October 3, 2015
IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancerXiaowei Chen, Michael J Churchill, Karan K Nagar, et al.
Bioorganic & Medicinal Chemistry|August 22, 2006
Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based designDésirée H H Tsao, Alan G Sutherland, Lee D Jennings, et al.
Nature Reviews. Drug Discovery|December 6, 2019
Rethinking drug design in the artificial intelligence eraPetra Schneider, W Patrick Walters, Alleyn T Plowright, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA-FtsZ interactionLee D Jennings, Ken W Foreman, Thomas S Rush, et al.
Pageof 30